How Years Of Copyright Maximalism Is Now Killing Pop Music | Techdirt

“Almost five years ago, we warned that years of copyright maximalists brainwashing the public about ever expansive copyright and the need for everything to be “owned” had resulted in the crazy Blurred Lines decision that said that merely being inspired by another artist to make a song that has a similar feel, even if it doesn’t copy any actual part of the music, was infringing. We warned that this would lead to bad things — and it has.

Over the last few years, we’ve been detailing story after story of similar cases being filed. It’s become so common that we don’t even bother to write about most of the cases. As we’ve said, though, this really is the industry reaping what they’ve sowed. It’s gotten so crazy that even the RIAA (yes, that RIAA) has felt the need to tell courts that maybe their interpretation of copyright has gone too far in the direction of over-protecting copyright holders.

It’s now become such a fact of life that the NY Times has a giant article on how copyright is basically eating pop music these days. …”

JMIR – Gimme My Damn Data (and Let Patients Help!): The #GimmeMyDamnData Manifesto | deBronkart | Journal of Medical Internet Research

Abstract:  Ten years ago, in 2009, “e-Patient Dave” deBronkart delivered an influential keynote speech at the Medicine 2.0 conference in Toronto, organized by the Journal of Medical Internet Research’s (JMIR’s) editor-in-chief Gunther Eysenbach, who themed the conference around the topics of participation, openness, collaboration, apomediation, and social networking to improve health care for the 21st century—with patient participation being a major component. Many see this as a defining event within the participatory medicine movement, perhaps the beginning of a social movement, similar to the women’s rights movement, with the title of Dave’s keynote “Gimme my damn data” becoming a rallying cry and hashtag for patients demanding more access to their electronic health records. On the occasion of the 20th anniversary of JMIR (and 10 years after the keynote), we are celebrating the impact of the keynote for the participatory medicine movement and #gimmemydamndata (also #GMDD) by publishing the transcript of these initial conversations as a manifesto of patients’ rights to access their data and their right to save their lives.


JMIR – Celebrating 20 Years of Open Access and Innovation at JMIR Publications | Eysenbach | Journal of Medical Internet Research

Abstract:  In this 20th anniversary theme issue, we are celebrating how JMIR Publications, an innovative publisher deeply rooted in academia and created by scientists for scientists, pioneered the open access model, is advancing digital health research, is disrupting the scholarly publishing world, and is helping to empower patients. All this has been made possible by the disintermediating power of the internet. And we are not done innovating: Our new series of “superjournals,” called JMIRx, will provide a glimpse into what we see as the future and end goal in scholarly publishing: open science. In this model, the vast majority of papers will be published on preprint servers first, with “overlay” journals then competing to peer review and publish peer-reviewed “versions of record” of the best papers.


JMIR – Preserving the Open Access Benefits Pioneered by the Journal of Medical Internet Research and Discouraging Fraudulent Journals | Wyatt | Journal of Medical Internet Research

Abstract:  The Journal of Medical Internet Research (JMIR) was an early pioneer of open access online publishing, and two decades later, some readers and authors may have forgotten the challenges of previous scientific publishing models. This commentary summarizes the many advantages of open access publishing for each of the main stakeholders in scientific publishing and reminds us that, like every innovation, there are disadvantages that we need to guard against, such as the problem of fraudulent journals. This paper then reviews the potential impact of some current initiatives, such as Plan S and JMIRx, concluding with some suggestions to help new open-access publishers ensure that the advantages of open access publishing outweigh the challenges.


Knowledge for all: A decade of open access at uOttawa | Gazette | University of Ottawa

“This month marks the 10th anniversary of uOttawa’s OA program—the first of its kind in Canada. By helping to make research freely available online, the University has positioned itself as a global leader in the transformation of scholarly communication….”

Knowledge for all: A decade of open access at uOttawa | Gazette | University of Ottawa

“This month marks the 10th anniversary of uOttawa’s OA program—the first of its kind in Canada. By helping to make research freely available online, the University has positioned itself as a global leader in the transformation of scholarly communication….”

Big Pharma has failed: the antibiotic pipeline needs to be taken under public ownership

“Looking into the past shows that public ownership of antibiotic R&D is not as radical as it may sound. During the second world war, allied research on penicillin – the most iconic antibiotic – was publicly financed, organised and owned. In fact, the original penicillin was never patented….”

How flipping a journal became about more than just open access – Digital Scholarship @ Leiden

“On January 14, 2019 the entire editorial board of Elsevier’s Journal of Informetrics (JOI) resigned. The editorial board wanted a journal with the same scope and same scientific standards, but owned by the International Society for Scientometrics and Informetrics (ISSI) (and not by the publisher), open access (instead of toll access) and with open citations. That is why, after resigning from JOI, they launched the new journal Quantitative Science Studies (QSS) with MIT Press [see news of the resignations and launch of the journal at the CWTS website and ISSI website respectively]. MIT Press participates in the Initiative for Open Citations (I4OC).

I interviewed Ludo Waltman (professor of Quantitative Science Studies and deputy director at the Centre for Science and Technology Studies (CWTS) at Leiden University) and Paul Wouters (Dean of the Faculty of Social and Behavioural Sciences, former director of CWTS and Open Science Coordinator at Leiden University) about the reasons for their decision and their views on the future of scholarly communication in general. …”

Why NIH is beefing up its data sharing rules after 16 years | Science | AAAS

“The U.S. National Institutes of Health last week released a draft policy that will require all investigators with NIH funding to make their data sets available to colleagues. For the first time, grantees holding any NIH-funded grant—not just those above a $500,000 threshold in direct costs—will need to submit a detailed plan for sharing data, including steps to protect the privacy of research subjects….”